Mikoto Tanabe¹, Hiroki Mizumaki¹, Tatsuya Imi², Takeshi Yoroidaka¹, Noriharu Nakagawa³, Ken Ishiyama¹, Hirohito Yamazaki¹, Yoshiraka Zaimoku¹, Takamasa Katagiri⁴, Kazuyoshi Hosomichi⁵, Atsushi Tajima⁵, Shinji Nakao¹ (1.Hematol., Kanazawa Univ., Kanazawa, Japan, 2.Keiju Kanazawa Hospital., Kanazawa, Japan, 3.Ishikawa Prefectural Central Hospital., Kanazawa, Japan, 4.Clinical Laboratory Sciences, Kanazawa University Graduate School, Kanazawa, Japan, 5.Bioinformatics and Genomics, Kanazawa University Graduate School, Kanazawa, Japan)

Tatsuya Imi^1,4, Ryosuke Ogawa², Kazuyoshi Hosomichi³, Hiroki Mizumaki¹, Noriharu Nakagawa¹, Takeshi Yoroidaka¹, Mikoto Tanabe¹, Noriaki Tsuji¹, Kohei Hosokawa¹, Hiroyuki Takamatsu¹, Ken Ishiyama¹, Yukio Kondo¹, Hirohito Yamazaki¹, Atsushi Tajima³, Shinji Nakao¹ (1.Hematology, Kanazawa University Hospital, Kanazawa, Japan, 2.Hematology and Oncology, JCHO Kyushu Hospital, Fukuoka, Japan, 3.Bioinformatics and Genomics, Kanazawa University, Kanazawa, Japan, 4.Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, Japan)

Shinichi Kako¹, Hirohito Yamazaki², Kazuteru Ohashi³, Takahiko Sato⁴, Shuichi Ota⁵, Yoshinobu Kanda¹, Tetsuo Maeda⁶, Jun Kato⁷, Ken Ishiyama¹³, Ken-Ichi Matsuoka⁸, Toshihiro Miyamoto⁹, Takahiro Fukuda¹⁰, Tatsuo Ichinohe¹¹, Yoshiko Atsuta¹², Takehiko Mori⁷ (1.Hematol., Saitama Medical Center, Jichi Medical Univ., Saitama, Japan, 2.Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan, 3.Hematol., Tokyo Metropolitan, Komagome Hospital, Tokyo, Japan, 4.Hematol., Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 5.Hematol., Sapporo Hokuyu Hospital, Sapporo, Japan, 6.Hematol. & Oncol., Osaka University Hospital, Osaka, Japan, 7.Hematol., Keio University School of Medicine, Tokyo, Japan, 8.Hematol/Oncol., Okayama University Hospital, Okayama, Japan, 9.Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 10.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 11.Hemaol. & Oncol., Hiroshima University, Hiroshima, Japan, 12.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 13.Hematol., Kanazawa University Hospital, Kanazawa, Japan)

Keijiro Sato¹, Ken Ishiyama², Masahisa Arahata², Kohei Hosokawa², Yukio Kondo², Hirohito Yamazaki³, Shinji Nakao² (1.Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan, 2.Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan, 3.Division of Transfusion Medcine, Kanazawa University Hospital, Kanazawa, Japan)

Yusuke Uchibori, Akira Hangaishi, Hiroki Hayashida, Yoshimasa Kamoda, Masako Hirao, Hiromitsu Iizuka, Michiko Kida, Kensuke Usuki (Department of Hematology, NTT medical center Tokyo, Tokyo, Japan)

Atsushi Narita¹, Hideki Muramatsu¹, Yinyan Xu¹, Eri Nishikawa¹, Nozomu Kawashima¹, Yusuke Okuno¹, Nobuhiro Nishio¹, Asahito Hama¹, Hirohito Yamazaki², Shinji Nakao³, Seiji Kojima¹, Yoshiyuki Takahashi¹ (1.Department of Pediatrics, Nagoya University, Nagoya, Japan, 2.Division of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan, 3.Department of Hematology, Kanazawa University, Kanazawa, Japan)